Alzheimer's Disease Research Center (ADRC) PET Component Study

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The purpose of this study is to further engage and characterize Alzheimer\'s Disease Research Center (ADRC) participants through additional research opportunities, particularly PET imaging. Amyloid and Tau PET imaging will be collected in 24 participants per year, for a total of 120 participants over five years. All participants will be followed longitudinally, including through potential transitions from normal aging to mild cognitive impairment (MCI) and Alzheimer\'s disease and related dementias (ADRD).
Epistemonikos ID: 63c17e8ba046968cf296218fbf64f9b533fe66db
First added on: Aug 12, 2026